The detection of relevant parameters in tumor tissues revealed increased PD-L1 and IFN-γ expression and enhanced tumor-infiltrating CD8+ and CD4+ T in the fascaplysin and anti-PD-1 combination therapy groups. The gene discussed is PDCD1; the disease is neoplasm.